SIGA Announces $13 Million of International Procurement Orders for Oral TPOXX® (Tecovirimat) Read more about SIGA Announces $13 Million of International Procurement Orders for Oral TPOXX® (Tecovirimat) SIGA to Participate in Alliance Global Partners’ Monkeypox Panel on Thursday, June 23rd 2022 Read more about SIGA to Participate in Alliance Global Partners’ Monkeypox Panel on Thursday, June 23rd 2022 How much medicine does the U.S. actually have to fight monkeypox? Read more about How much medicine does the U.S. actually have to fight monkeypox? Clinical features and management of human monkeypox: a retrospective observational study in the UK Read more about Clinical features and management of human monkeypox: a retrospective observational study in the UK Siga gets requests for smallpox drug in Europe as monkeypox spreads Read more about Siga gets requests for smallpox drug in Europe as monkeypox spreads CDC treats first monkeypox patient with SIGA's smallpox antiviral via expanded access Read more about CDC treats first monkeypox patient with SIGA's smallpox antiviral via expanded access Monkeypox: a neglected old foe Read more about Monkeypox: a neglected old foe UK logs another 104 monkeypox cases as outbreak of rash-causing virus keeps sweeping the country Read more about UK logs another 104 monkeypox cases as outbreak of rash-causing virus keeps sweeping the country Monkeypox in 2022—What Clinicians Need to Know Read more about Monkeypox in 2022—What Clinicians Need to Know SIGA Receives Approval from the FDA for Intravenous (IV) Formulation of TPOXX® (tecovirimat) Read more about SIGA Receives Approval from the FDA for Intravenous (IV) Formulation of TPOXX® (tecovirimat) Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last » Subscribe to
SIGA Announces $13 Million of International Procurement Orders for Oral TPOXX® (Tecovirimat) Read more about SIGA Announces $13 Million of International Procurement Orders for Oral TPOXX® (Tecovirimat)
SIGA to Participate in Alliance Global Partners’ Monkeypox Panel on Thursday, June 23rd 2022 Read more about SIGA to Participate in Alliance Global Partners’ Monkeypox Panel on Thursday, June 23rd 2022
How much medicine does the U.S. actually have to fight monkeypox? Read more about How much medicine does the U.S. actually have to fight monkeypox?
Clinical features and management of human monkeypox: a retrospective observational study in the UK Read more about Clinical features and management of human monkeypox: a retrospective observational study in the UK
Siga gets requests for smallpox drug in Europe as monkeypox spreads Read more about Siga gets requests for smallpox drug in Europe as monkeypox spreads
CDC treats first monkeypox patient with SIGA's smallpox antiviral via expanded access Read more about CDC treats first monkeypox patient with SIGA's smallpox antiviral via expanded access
UK logs another 104 monkeypox cases as outbreak of rash-causing virus keeps sweeping the country Read more about UK logs another 104 monkeypox cases as outbreak of rash-causing virus keeps sweeping the country
Monkeypox in 2022—What Clinicians Need to Know Read more about Monkeypox in 2022—What Clinicians Need to Know
SIGA Receives Approval from the FDA for Intravenous (IV) Formulation of TPOXX® (tecovirimat) Read more about SIGA Receives Approval from the FDA for Intravenous (IV) Formulation of TPOXX® (tecovirimat)